BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9770649)

  • 1. NMR study and comparison of the antigenic properties of a peptide recognized by two HIV-1 neutralizing antibodies.
    Tsang P; Mu X; Wu G; Durda PJ
    J Mol Recognit; 1997; 10(6):256-61. PubMed ID: 9770649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies.
    Sharon M; Görlach M; Levy R; Hayek Y; Anglister J
    Protein Expr Purif; 2002 Apr; 24(3):374-83. PubMed ID: 11922753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide.
    Tugarinov V; Zvi A; Levy R; Anglister J
    Nat Struct Biol; 1999 Apr; 6(4):331-5. PubMed ID: 10201400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 peptide vaccine candidates: selecting constrained V3 peptides with highest affinity to antibody 447-52D.
    Mester B; Manor R; Mor A; Arshava B; Rosen O; Ding FX; Naider F; Anglister J
    Biochemistry; 2009 Aug; 48(33):7867-77. PubMed ID: 19552398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity.
    Sharon M; Rosen O; Anglister J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):601-12. PubMed ID: 16159022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
    Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
    J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody.
    Lee HK; Scanlan CN; Huang CY; Chang AY; Calarese DA; Dwek RA; Rudd PM; Burton DR; Wilson IA; Wong CH
    Angew Chem Int Ed Engl; 2004 Feb; 43(8):1000-3. PubMed ID: 14966891
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
    Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
    Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1-specific polyclonal and monoclonal antibodies raised with synthetic peptides: characterization and applications.
    Laman JD; Schellekens MM; Paddenburg D; Tersmette M; Langedijk JP; Boersma WJ; Claassen E
    Year Immunol; 1993; 7():63-8. PubMed ID: 7690509
    [No Abstract]   [Full Text] [Related]  

  • 13. Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.
    Weliky DP; Bennett AE; Zvi A; Anglister J; Steinbach PJ; Tycko R
    Nat Struct Biol; 1999 Feb; 6(2):141-5. PubMed ID: 10048925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.
    Huang X; Barchi JJ; Lung FD; Roller PP; Nara PL; Muschik J; Garrity RR
    Biochemistry; 1997 Sep; 36(36):10846-56. PubMed ID: 9312273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotope-edited NMR studies of Fab'-peptide complexes.
    Tsang P; Fieser TM; Ostresh JM; Lerner RA; Wright PE
    Pept Res; 1988; 1(2):87-92. PubMed ID: 2980784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural studies of human HIV-1 V3 antibodies.
    Stanfield RL; Wilson IA
    Hum Antibodies; 2005; 14(3-4):73-80. PubMed ID: 16720977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of a glycoprotein 120 V3 loop peptide to HIV-1 neutralizing antibodies. Structural implications.
    Wu G; MacKenzie R; Durda PJ; Tsang P
    J Biol Chem; 2000 Nov; 275(47):36645-52. PubMed ID: 10967109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR structure of the principal neutralizing determinant of HIV-1 displayed in filamentous bacteriophage coat protein.
    Jelinek R; Terry TD; Gesell JJ; Malik P; Perham RN; Opella SJ
    J Mol Biol; 1997 Mar; 266(4):649-55. PubMed ID: 9102458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.